From: A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
Variables | Univariate Cox regression | Multivariate Cox regression | ||
---|---|---|---|---|
HR (95Â % CI) | P value | HR (95Â % CI) | P value | |
Training set | ||||
 Age | 0.9822 (0.9438–1.0221) | 0.3767 | 1.0038 (0.9630–1.0463) | 0.8581 |
 Gender | 0.4531 (0.1660–1.2370) | 0.1224 | 0.4317 (0.1436–1.2977) | 0.1347 |
 Tumor stage | 3.1198 (1.8313–5.3147) | < 0.0001 | 2.4005 (0.9082–6.3452) | 0.0774 |
 T classification | 2.2977 (1.3818–3.8204) | 0.0013 | 0.8041 (0.3037–2.1291) | 0.6608 |
 riskScore | 1.0084 (1.0054–1.0114) | <0.0001 | 1.0060 (1.0019–1.0102) | 0.0038 |
Testing set | ||||
 Age | 1.0232 (0.9823–1.0659) | 0.2702 | 1.0172 (0.9672–1.0697) | 0.5075 |
 Gender | 0.9556 (0.3160–2.8902) | 0.9360 | 0.7268 (0.2087–2.5312) | 0.6162 |
 Tumor stage | 2.2629 (1.5483–3.3074) | < 0.0001 | 1.6502 (0.7047–3.8642) | 0.2486 |
 T classification | 2.1696 (1.4254–3.3023) | 0.0003 | 1.5756 (0.5769–4.3033) | 0.3751 |
 riskScore | 1.0119 (1.0070–1.0168) | < 0.0001 | 1.0126 (1.0057–1.0196) | 0.0004 |
Combination set | ||||
 Age | 1.0036 (0.9756–1.0324) | 0.8033 | 1.0167 (0.9863–1.0479) | 0.2847 |
 Gender | 0.6599 (0.3170–1.3734) | 0.2663 | 0.7614 (0.3577–1.6208) | 0.4795 |
 Tumor stage | 2.5702 (1.8967–3.4829) | < 0.0001 | 2.7575 (1.5812–4.8087) | 0.0004 |
 T classification | 2.1839 (1.5849–3.0093) | < 0.0001 | 0.7615 (0.4087–1.4188) | 0.3909 |
 riskScore | 1.0085 (1.0060–1.0110) | < 0.0001 | 1.0061 (1.0032–1.0090) | < 0.0001 |